Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Rheumatic Disease ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Systemic sclerosis.Nat Rev Dis Prim. 2015; 1: 15002
- The cost of systemic sclerosis.Arthritis Rheum. 2009; 61: 119-123
- Healthcare costs of inflammatory myopathies.J Rheumatol. 2011; 38: 885-888
- Daily occupations--performance, satisfaction and time use, and relations with well-being in women with limited systemic sclerosis.Disabil Rehabil. 2008; 30: 27-35
- Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life.Rheumatology. 2018; 57: 73-83
- Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment-A Systematic Literature Review.Int J Environ Res Public Health. 2019; 16: 2966
- Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample.Rheumatology. 2018; 57: 1611-1622
- Humanistic and cost burden of systemic sclerosis: A review of the literature.Autoimmun Rev. 2017; 16: 1147-1154
- Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis.J Rheumatol. 2001; 28: 2031-2037
- Annual medical costs and healthcare resource use in patients with systemic sclerosis in an insured population.J Rheumatol. 2012; 39: 2303-2309
- Cost-of-illness of scleroderma: the case for rare diseases.Semin Arthritis Rheum. 1997; 27: 73-84
- Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United States.J Rheumatol. 2019; 46: 920-927
- Longitudinal analysis of direct medical costs for systemic sclerosis patients: a population- based study.2013
- Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study.Medicine (Baltim). 2017; 96: e8503
- Work Productivity and Economic Burden of Systemic Sclerosis in a Multiethnic Asian Population.Arthritis Care Res. 2022; 74: 818-827
- Social/economic costs and health-related quality of life in patients with scleroderma in Europe.Eur J Health Econ. 2016; 17: 109-117
- The economic burden and health-related quality of life associated with systemic sclerosis in France.Scand J Rheumatol. 2015; 44: 238-246
- Social economic costs and health-related quality of life in patients with systemic sclerosis in Spain.Arthritis Care Res. 2014; 66: 473-480
- Cost-of-illness of patients with systemic sclerosis in a tertiary care centre.Rheumatology. 2010; 49: 1920-1928
- Economic Burden and Management of Systemic Sclerosis-Associated Interstitial Lung Disease in 8 European Countries: The BUILDup Delphi Consensus Study.Adv Ther. 2021; 38: 521-540
- Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population-based cohort study.Respirology. 2022; 27: 341-349
- Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France.Front Med. 2021; 8: 699532
- Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database Analysis.Adv Ther. 2020; 37: 2460-2476
- Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis.Adv Ther. 2019; 36: 1100-1113
- All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement.J Rheumatol. 2018; 45: 235-241
- The clinical and economic burden of systemic sclerosis related interstitial lung disease.Rheumatology. 2020; 59: 1878-1888
- The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia.BMC Pulm Med. 2019; 19: 226
- Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden.Arthritis Res Ther. 2019; 21: 299
- The social costs of digital ulcer management in sclerodema patients: an observational Italian pilot study.Joint Bone Spine. 2010; 77: 83-84
- Determinants of unemployment amongst Australian systemic sclerosis patients: results from a multicentre cohort study.Clin Exp Rheumatol. 2016; 34: 79-84
- Hospitalization Rates Are Highest in the First 5 Years of Systemic Sclerosis: Results From a Population-based Cohort (1980-2016).J Rheumatol. 2021; 48: 877-882
- AB0788 Epidemiology of systemic sclerosis in sardinia. analysis of hospitalization data in the decade 2001-2010.Ann Rheum Dis. 2013; 72: A1031-A
- [Cost-of-illness in systemic sclerosis: a retrospective study of an Italian cohort of 106 patients].Reumatismo. 2003; 55: 245-255
Article info
Publication history
Published online: March 01, 2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.
